Alzemend Neuro Reports Full Data Set From Phase 1 Trial For AL001 Treatment Of Dementia Related To Alzheimer's: 'Data confirm the positive topline results announced in December 2021 demonstrating AL001 in plasma is bioequivalent to marketed lithium...'

Never miss a trade again with the fastest news alerts in the world!

This headline only article is a sample of real-time intelligence Benzinga Pro traders use to win in the markets everyday.

Want the fastest, most accurate stock market intelligence? Want EXCLUSIVE stories originated by Benzinga reporters? Join 10,000+ serious traders in the Benzinga Pro community!